Reliability and structural validity of the Multidimensional Fatigue Inventory (MFI) in patients with idiopathic Parkinson's disease

Parkinsonism and Related Disorders

Volumn 18, Issue 5, 2012, Pages 532-536

  Elbers, Roy G ^a,b   van Wegen, Erwin E H ^b   Verhoef, John ^a   Kwakkel, Gert ^b  

^a UNIVERSITY OF APPLIED SCIENCES LEIDEN   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Assessment; Fatigue; Multidimensional Fatigue Inventory; Parkinson disease; Psychometrics

Indexed keywords

ADULT; AGED; ARTICLE; BLAND AND ALTMANN ANALYSIS; CLINICAL ASSESSMENT TOOL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION COEFFICIENT; CRONBACH ALPHA COEFFICIENT; DISEASE SEVERITY; FATIGUE; FEMALE; HUMAN; INTERNAL CONSISTENCY; MAJOR CLINICAL STUDY; MALE; MEASUREMENT ERROR; MULTIDIMENSIONAL FATIQUE INVENTORY; PARKINSON DISEASE; PATIENT ASSESSMENT; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SMALLEST DETECTABLE CHANGE; STATISTICAL ANALYSIS; STATISTICAL PARAMETERS; STRUCTURAL VALIDITY; TEST RETEST RELIABILITY; VALIDITY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FATIGUE; FEMALE; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; PRINCIPAL COMPONENT ANALYSIS; PSYCHOMOTOR PERFORMANCE; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 84861188817     PISSN: 13538020     EISSN: 18735126     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2012.01.024     Document Type: Article

References (30)

1. Havlikova E., Rosenberger J., Nagyove I., Middel B., Dubayova T., Gdovinova Z., et al. Impact of fatigue on quality of life in patients with Parkinson's disease. Eur J Neurol 2008, 15:475-480.
2. Herlofson K., Larsen J. The influence of fatigue on health-related quality of life in patients with Parkinson's disease. Acta Neurol Scand 2003, 107:1-6.
3. Martínez-Martín P., Catalan M., Benito-León J., Ortega Moreno A., Zamarbide I., Cubo E., et al. Impact of fatigue in Parkinson's disease: the fatigue impact scale for daily use (D-FIS). Qual Life Res 2006, 15:597-606.
4. Alves G., Wentzel-Larsen T., Larsen J. Is fatigue an independent and persistent symptom in patients with Parkinson's disease?. Neurology 2004, 63:1908-1911.
5. Herlofson K., Larsen J. Measuring fatigue in patients with Parkinson's disease - the fatigue severity scale. Eur J Neurol 2002, 9:595-600.
6. Lou J. Physical and mental fatigue in Parkinson's diseae: epidemiology, pathophysiology and treatment. Drugs and Aging 2009, 26:195-208.
7. Friedman J., Brown R., Comella C., Garber C., Krupp L., Lou J., et al. Fatigue in Parkinson's disease: a review. Mov Disord 2007, 22:297-308.
8. Smets E., Garsen B., Bonke B., de Haes J. The multidimensional fatigue inventory (MFI) psychometric qualities of an instrument to assess fatigue. J Psychosom Res 1995, 39:315-325.
9. Chaudhuri A., Behan P. Fatigue in neurological disorders. Lancet 2004, 363:978-988.
10. Friedman J., Alves G., Hagell P., Marinus J., Marsh L., Martínez-Martín P., et al. Fatigue rating scales critique and recommendations by the Movement Disorders Society Task Force on rating scales for Parkinson's disease. Mov Disord 2010, 25:805-822.
11. Elbers R, Rietberg M, van Wegen E, Verhoef J, Kramer S, Terwee C, et al. Self-report fatigue questionnaires in multiple sclerosis, Parkinson's disease and stroke: a systematic review of measurement properties. Qual Life Res, published online 20 October 2011, doi:10.1007/s11136-011-0009-2.
12. Nieuwboer A., Kwakkel G., Rochester L., Jones D., van Wegen E., Willems A., et al. Cueing training in the home improves gait-related mobility in Parkinson's disease: the Rescue trial. J Neurol Neurosurg Psychiatry 2007, 78:134-140.
13. Hughes A., Daniel S., Kilford L., Lees A. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinic-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992, 55:181-184.
14. Hoehn M., Yahr M. Parkinsonism: onset, progression, and mortality. Neurology 1967, 5:427-442.
15. Recent developments in Parkinson's disease 1987, vol. 2:153-163. Macmillan Health Care Information, Florham Park, NJ.
16. Folstein M., Folstein S. Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975, 12:189-198.
17. Smets E., Garsen B., Cull A., de Haes J. Application of the multidimensional fatigue inventory (MFI-20) in cancer patients receiving radiotherapy. Br J Cancer 1996, 73:241-245.
18. Mokkink L., Terwee C., Patrick D., Alonso J., Stratford P., Knol D., et al. The COSMIN study reached international consensus on taxonomy, terminology, and definitions of measurement properties for health-related patient-reported outcomes. J Clin Epidemiol 2010, 63:737-745.
19. Terwee C., Bot S., de Boer M., van der Windt D., Knol D., Dekker J., et al. Quality criteria were proposed for measurement properties of health status questionnaires. J Clin Epidemiol 2007, 60:34-42.
20. Bland J., Altman D. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986, 1:307-310.
21. De Vet H., Terwee C., Knol D., Bouter L. When to use agreement versus reliability measures. J Clin Epidemiol 2006, 59:1033-1039.
22. Goligher E., Pouchot J., Brant R., Kherani R., Aviña-Zubieta J., Lacaille D., et al. Minimal clinically important difference for 7 measures of fatigue in patients with systemic lupus erythematosus. J Rheumatol 2008, 35:635-642.
23. Pouchot J., Kherani R., Brant R., Lacaille D., Lehman A., Ensworth S., et al. Determination of the minimal clinically important difference for seven fatigue measures in rheumatoid arthritis. J Clin Epidemiol 2008, 61:705-713.
24. Purcell A., Fleming J., Bennett S., Burtmeister B., Haines T. Determining the minimal clinically important difference criteria for the multidimensional fatigue inventory in a radiotherapy population. Support Care Cancer 2010, 18:307-315.
25. Revicky D., Hays R., Cella D., Sloan J. Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes. J Clin Epidemiol 2008, 61:102-109.
26. Fillion L., Gélinas C., Simard S., Savard J., Gagnon P. Validation evidence for the French Canadian adaptation of the multidimensional fatigue inventory as a measure of cancer-related fatigue. Cancer Nurs 2003, 26:143-154.
27. Gentile S., Delarozière J., Favre F., Sambuc R., San Marco J. Validation of the French 'multidimensional fatigue inventory' (MFI 20). Eur J Cancer Care 2003, 12:58-64.
28. Benito-León, Martínez-Martín P., Frades B., Martínez-Ginés M., de Andrés C., Meca-Lallana J., et al. Impact of fatigue in multiple sclerosis: the fatigue impact scale for daily use (D-FIS). Mult Scler 2007, 13:645-651.
29. Elbers R., van Wegen E., Rochester L., Hetherington V., Nieuwboer A., Willems A., et al. Is impact of fatigue an independent factor associated with physical activity in patients with idiopathic Parkinson's disease?. Mov Disord 2009, 24:1512-1518.
30. Lou J., Kearns G., Oken B., Sexton G., Nutt J. Exacerbated physical fatigue and mental fatigue in Parkinson's disease. Mov Disord 2001, 16:190-196.